News Focus
News Focus
Post# of 257278
Next 10
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 86321

Tuesday, 01/26/2010 8:56:41 PM

Tuesday, January 26, 2010 8:56:41 PM

Post# of 257278
MNTA Insider Shareholdings

[Updated for SEC filings through 1/26/10. The tallies
below include both ordinary and restricted shares
and both vested and non-vested options.]


Executive Officers
*Craig Wheeler, CEO 412,344 shares 575,000 options
G. Venkataraman, SVP R&D 465,340 shares 163,200 options
Steven Brugger, COO 280,089 shares 185,556 options
*John Bishop, SVP Pharma 42,100 shares 168,680 options
Bruce Leicher, Gen Counsel 29,653 shares 113,300 options
James Roach, CMO 9,500 shares 181,500 options
*Richard Shea, CFO 33,432 shares 225,450 options
===== ========= =========
7 Executive Officers 1,272,458 shares 1,612,686 options


Non-executive Directors
John Clarke 77,123 shares 111,000 options
Alan Crane 578,602 shares 88,600 options
Bruce Downey† 0 shares 30,000 options
Marsha Fanucci 0 shares 111,000 options
Peter Hutt 67,863 shares 186,500 options
*Ram Sasisekharan 381,344 shares 111,000 options
*Bennett Shapiro 7,000 shares 125,450 options
Elizabeth Stoner 0 shares 64,200 options
James Sulat‡ 0 shares 45,000 options
===== ========= =======
9 Non-executive Dirctrs 1,111,932 shares 872,750 options


All Officers/Directors 2,384,390 shares 2,485,436 options


*10b5-1 selling plan in effect.
†Joined BoD 6/11/09.
‡Joined BoD 6/5/08.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today